Full days through 2026-11-08 (America/Phoenix) · Updated 2026-11-09 16:14 MST
Last 30 days: $19,480 collected (-7.1% vs the prior 30). 73 active payers, 283 past payers in the win-back pool. $12,030 sitting in 23 open invoices (22 overdue).
Revenue, last 30 days
$19,480
▼ 7.1% vs prior 30 ($20,975)
Revenue, month to date
$7,210
Yesterday: $120
Revenue, last 7 days
$6,660
Trailing 12 months
$317,515
Average ticket, 30 days
$361
35 payers in 30 days
Open invoices
$12,030
23 open · 22 overdue ($11,580)
Active payers
73
Paid in the last 90 days
Win-back pool
283
Past payers to win back
New customers, 30 days
11
3 in the last 7 days
Customers total
1,090
Everyone in the database
Top product, 30 days
Tirzepatide
60.1% of sales · GLP-1 is 77.2%
Failed charges, 30 days
4
Worth a retry nudge
Revenue by month
Revenue by week
Who is in the database
Active payers736.7%
Win-back pool28326.0%
Leads, never paid978.9%
Other contacts63758.4%
What sold, last 30 days
Tirzepatide$10,32060.1%
Semaglutide$2,95017.2%
BPC-family$1,0756.3%
Unspecified$9355.4%
IV/Drip$6253.6%
NAD$3001.7%
Other$9755.7%
Top product: Tirzepatide at 60.1% of sales. GLP-1 share: 77.2%.